Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
527.00    2.00 (0.38%)
Bid:
522.00
Ask:
528.00
Spread: 6.00 (1.149%)
Market Cap: £303.25m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Board Changes

23 Apr 2024 07:00

RNS Number : 5896L
Mortgage Advice Bureau (Hldgs) PLC
23 April 2024
 

23 April 2024

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Company")

Chief Financial Officer and Non-Executive Director appointments

MAB is pleased to announce the appointments of:

· Emilie McCarthy as Chief Financial Officer of the Company, with effect from 22 May 2024; and,

· Rachel Haworth as independent Non-Executive Director of the Company, with effect from 1 May 2024. Rachel will chair the Remuneration Committee and will serve on the Audit, Nomination and Group Risk Committees.

Emilie McCarthy has over 20 years of international experience across finance, risk management, and operations, working in the UK and the US. Before joining MAB, she held Chief Financial Officer roles at Hult International Business School and CNBC International, where she led global teams and drove the growth of new diversified revenue streams, strategic change and geographical expansion, and finance transformation programmes. She started her career with a 13-year tenure at General Electric, progressing through various finance leadership roles focused on financial services. Emilie holds a Masters of Science in Management with a major in Accounting and Finance from Neoma Business School in France.

Rachel Haworth has extensive experience in the financial services industry. She is a Non-Executive Director and Chair of the Remuneration Committee for Mansfield Building Society, and a Non-Executive Member of the Phoenix Independent Governance Committees covering the Phoenix, Standard Life and ReAssure brands. Her executive experience includes HSBC First Direct and more recently Customer Experience Director for Coventry Building Society. Rachel's expertise spans strategy, marketing, digital transformation, risk management and cultural leadership, and she is a Fellow of the Chartered Institute of Marketing.

Both appointments are subject to Regulatory Approval.

Peter Brodnicki, Chief Executive Officer, said:

"I am delighted to welcome Emilie and Rachel to the Board.

"Emilie is an experienced CFO and leader. Her appointment follows a thorough selection process during which she impressed us with her financial credentials, her leadership and wide-ranging corporate skills, as well as her strategic acumen. She shares the same entrepreneurial culture that has been essential to our success as a business, and I very much look forward to her contribution to our next phase of growth.

"Rachel is a very experienced executive and non-executive who has operated in the Financial Services industry for over three decades. She will bring a wealth of experience to MAB and is a great addition to our Board."

 

Emilie Nadia Marcelline McCarthy, née Burgaud, aged 43, currently holds or has held the following directorships and partnerships in the last five years:

Current directorships/partnerships

Past directorships/partnerships

N/a

Ashridge Educational Services Ltd

CNBC (UK) Ltd

NBC (UK) Holdings Ltd

 

Rachel Cecilia Haworth, née Hughes, aged 52, currently holds or has held the following directorships and partnerships in the last five years:

Current directorships/partnerships

Past directorships/partnerships

Mansfield Building Society

N/a

 

There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) or Rule 17 of the AIM Rules for Companies.

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

Enquiries:

Mortgage Advice Bureau (Holdings) plc

  +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Deutsche Numis

Stephen Westgate / Giles Rolls

 

 

 +44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEDFUEELSEDL
Date   Source Headline
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.